NeXstar Pharmaceuticals Inc.
Division of Gilead Sciences Inc.
Latest From NeXstar Pharmaceuticals Inc.
Biopharma R&D Productivity And Growth 2017: Big Pharma Closes The Gap
Catenion updates its annual list of the year's top pharma R&D performers. R&D productivity declined for the first time since 2014. Mid pharmas continue to dominate the top 10, but big pharmas are making inroads.
Clovis CEO Sees Rosy Future With Rubraca
Success in the ARIEL3 trial for its ovarian cancer agent and a collaboration with Bristol-Myers Squibb has put Clovis in a healthy position, CEO Patrick Mahaffy tells Scrip.
Biopharma: Beyond the First Product
Vertex: Sticking To Its Story
Company Information
- Industry
-
Biotechnology
- Antisense, Oligonucleotides
- Large Molecule
- Pharmaceuticals
- Therapeutic Areas
- Cancer
- Infectious & Viral Diseases
- Inflammation
- Alias(es)
- Ownership
- Private
- Headquarters
-
Worldwide
-
North America
-
USA
-
USA
-
North America
- Parent & Subsidiaries
- Gilead Sciences Inc.
- Senior Management
- Contact Info
-
NeXstar Pharmaceuticals Inc.
Phone: (909) 394-4000
650 Cliffside Dr.
San Dimas, CA 91773
USA
You must sign in to use this functionality
Authentication.SignIn.HeadSignInHeader
Email Company
All set! This article has been sent to my@email.address.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
DCD.EmailPopout.Notice